Sio Gene Therapies Inc
(SIOX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Operating Expenses | 9,834 | 16,053 | 13,676 | 11,884 | 27,558 |
| Operating Income | -9,834 | -16,053 | -13,676 | -11,884 | -27,558 |
| Interest Expense | 796 | 440 | 1,066 | 1,313 | 1,558 |
| Other Income | 2,066 | 127 | 694 | -560 | 1,097 |
| Pre-tax Income | -8,564 | -16,366 | -14,048 | -13,757 | -28,019 |
| Income Tax | 30 | 282 | -9 | 127 | 38 |
| Net Income Continuous | -8,594 | -16,648 | -14,039 | -13,884 | -28,057 |
| Net Income | $-8,594 | $-16,648 | $-14,039 | $-13,884 | $-28,057 |
| EPS Basic Total Ops | -0.20 | -0.47 | -0.62 | -0.61 | -1.23 |
| EPS Basic Continuous Ops | -0.20 | -0.47 | -0.62 | -0.61 | -1.23 |
| EPS Diluted Total Ops | -0.20 | -0.47 | -0.62 | -0.61 | -1.23 |
| EPS Diluted Continuous Ops | -0.20 | -0.47 | -0.62 | -0.61 | -1.23 |
| EBITDA(a) | $-9,342 | $-15,751 | $-13,235 | $-11,576 | $-27,132 |